Why is Windlas Biotech falling/rising?

As of 23-Sep, Windlas Biotech Ltd is currently priced at 950.00, reflecting an increase of 6.05 or 0.64%. Despite this positive movement today, the stock has experienced a decline of 4.90% over the past week and 6.30% over the past month. It is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend in the short term. However, the stock has shown resilience with a 9.95% return over the past year and a remarkable 310.72% increase over the last three years. The company has demonstrated strong financial performance, with record net sales and profits in its latest quarterly results, and a low debt-to-equity ratio, which supports its valuation despite trading at a premium compared to peers.
In the broader market context, while Windlas Biotech has underperformed the Sensex in the short term, with a 1-month decline compared to the index's 0.98% gain, it has outperformed the sector today by 0.99%. The rising investor participation, as evidenced by a significant increase in delivery volume, suggests growing interest in the stock despite its recent struggles. The company's consistent returns over the last three years and the backing of majority shareholders, the promoters, further bolster its position, indicating that while the stock may face short-term challenges, its long-term outlook remains positive.